Literature DB >> 26064291

Changes of serum TNF-α, IL-5 and IgE levels in the patients of mycoplasma pneumonia infection with or without bronchial asthma.

Lan Wang1, Qiang Chen1, Cuiqin Shi1, Hanjing Lv1, Xianghuai Xu1, Li Yu1.   

Abstract

OBJECTIVE: This study aimed to investigate the changes of serum levels of TNF-α, IL-5 and IgE in mycoplasma pneumonia (MP) infection patients with or without bronchial asthma and explore its clinical importance.
METHODS: ELISA and Western blot assay were performed to detect the serum levels of TNF-α, IL-5 and IgE in 35 healthy subjects, 45 patients with MP infection and 40 bronchial asthma patients with MP infection.
RESULTS: The serum levels of TNF-α, IL-5 and IgE in MP infection patients and asthma patients with MP infection were significantly higher than those in healthy subjects (P<0.01). Moreover, the serum levels of TNF-α, IL-5 and IgE in asthma patients with MP infection was markedly higher than those in MP infection patients (P<0.05). Correlation analysis showed serum TNF-α was positively associated with serum IL-5 (r=0.9636, P<0.01), serum TNF-α positively related to IgE (r=0.9841, P<0.01) and serum IgE positively relevant with serum IL-5 (r=0.9572, P<0.01) in asthma patients with MP infection.
CONCLUSION: Our findings indicate that serum levels of TNF-α, IL-5 and IgE may play important roles in the pathogenesis of MP infection, especially in asthma patients.

Entities:  

Keywords:  Enzyme-linked immunosorbent assay; IL-5; IgE; Mycoplasma pneumoniae infection; TNF-α; bronchial asthma

Year:  2015        PMID: 26064291      PMCID: PMC4443125     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  16 in total

1.  Differential microRNA epression in asthma and the role of miR-1248 in regulation of IL-5.

Authors:  Ronaldo Paolo L Panganiban; Mark H Pinkerton; Saumya Y Maru; Sarah J Jefferson; Alanna N Roff; Faoud T Ishmael
Journal:  Am J Clin Exp Immunol       Date:  2012-11-15

Review 2.  Chinese guideline for the prevention and management of bronchial asthma (Primary Health Care Version).

Authors: 
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

3.  Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma.

Authors:  Jay Peters; Harjinder Singh; Edward G Brooks; Joseph Diaz; Thirumalai R Kannan; Jacqueline J Coalson; Janet G Baseman; Marianna Cagle; Joel B Baseman
Journal:  Chest       Date:  2011-05-26       Impact factor: 9.410

4.  Clinical severity of Mycoplasma pneumoniae (MP) infection is associated with bacterial load in oropharyngeal secretions but not with MP genotype.

Authors:  Anna C Nilsson; Per Björkman; Christina Welinder-Olsson; Anders Widell; Kenneth Persson
Journal:  BMC Infect Dis       Date:  2010-02-25       Impact factor: 3.090

Review 5.  Mycoplasma pneumoniae and its role in asthma.

Authors:  Nazima Nisar; Randeep Guleria; Sanjay Kumar; Tirlok Chand Chawla; Nihar Ranjan Biswas
Journal:  Postgrad Med J       Date:  2007-02       Impact factor: 2.401

6.  The significance of a rapid cold hemagglutination test for detecting mycoplasma infections in children with asthma exacerbation.

Authors:  Ya Ting Chang; Yao Hsu Yang; Bor Luen Chiang
Journal:  J Microbiol Immunol Infect       Date:  2006-02       Impact factor: 4.399

7.  Is TNF a link between aging-related reproductive endocrine dyscrasia and Alzheimer's disease?

Authors:  Ian A Clark; Craig S Atwood
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

8.  ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens.

Authors:  T R Kannan; Joel B Baseman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-14       Impact factor: 11.205

Review 9.  Targeting TNF-alpha: a novel therapeutic approach for asthma.

Authors:  Christopher Brightling; Mike Berry; Yassine Amrani
Journal:  J Allergy Clin Immunol       Date:  2007-11-26       Impact factor: 10.793

10.  Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity.

Authors:  David L Hahn; Allison Schure; Katir Patel; Tawanna Childs; Eduard Drizik; Wilmore Webley
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

View more
  5 in total

1.  The Immunopathologic Effects of Mycoplasma pneumoniae and Community-acquired Respiratory Distress Syndrome Toxin. A Primate Model.

Authors:  Diego J Maselli; Jorge L Medina; Edward G Brooks; Jacqueline J Coalson; Thirumalai R Kannan; Vicki T Winter; Molly Principe; Marianna P Cagle; Joel B Baseman; Peter H Dube; Jay I Peters
Journal:  Am J Respir Cell Mol Biol       Date:  2018-02       Impact factor: 6.914

2.  Serum Cytokines and FeNO in School-Aged Children with Mycoplasma pneumoniae Pneumonia.

Authors:  Hai-Li Jin; Lu Zhan; Shu-Fen Mei; Zheng-Yang Shao
Journal:  Med Sci Monit       Date:  2020-06-21

3.  Clinical Efficacy of Methotrexate Combined with Iguratimod on Patients with Rheumatoid Arthritis and Its Influence on the Expression Levels of HOTAIR in Serum.

Authors:  Jingya Tan; Jiaqiang Dan; Yi Liu
Journal:  Biomed Res Int       Date:  2021-11-12       Impact factor: 3.411

4.  Efficacy of human immunoglobulin injection and effects on serum inflammatory cytokines in neonates with acute lung injury.

Authors:  Shaohua Wang; Zanmei Tang; Xuemei Zheng; Jian Deng; Zhangxing Wang
Journal:  Exp Ther Med       Date:  2021-07-01       Impact factor: 2.447

5.  High immunoglobulin E level is associated with increased readmission in children with bronchopneumonia.

Authors:  Cun You; Guo Ran; Xiao Wu; Yu Wang; Hua Tian; Jiabao Fan; Zezhong Yao; Fei Wang
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.